Ashok Kumar Jain
About Ashok Kumar Jain
Data last updated:
Ashok Kumar Jain is a Partner at Alpha Alternatives Msar Llp (since 2024) and Director at Nextgen In-Vitro Diagnostics Private Limited (since 2020). The companies operate in Financial Services and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹4,488 Cr; the largest is Alpha Alternatives Msar Llp at ₹4,486 Cr (FY 2025). Earlier, Ashok Kumar Jain was a Whole-Time Director at Avantor Performance Materials India Private Limited (2006–2019) and Director at J.T. Baker Chemicals Private Limited (from 2012).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alpha Alternatives Msar Llp AAW-2814 | Partner | 03 Jun 2024 | 2021 | ₹4,486 Cr (FY 2025) | Active |
 Nextgen In-Vitro Diagnostics Private Limited U33110DL2015PTC279481 | Director | 02 Mar 2020 | 2015 | ₹1.87 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Avantor Performance Materials India Private Limited U24209HR1991PTC048501 | Whole-Time Director | 01 Dec 2006 | 1991 | ₹887 Cr (FY 2023) | Active |
| J.T. Baker Chemicals Private Limited U51109MH2009PTC191942 | Director | 10 May 2012 | 2009 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ashok Kumar Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mudit Singhania | 06756767 | Alpha Alternatives Msar Llp | Designated Partner |
| Shreyans Hitendrakumar Mehta | 06756771 | Alpha Alternatives Msar Llp | Designated Partner |
| Devashish Ohri | 03266071 | Nextgen In-Vitro Diagnostics Private Limited | Managing Director |
| Sushil Mehta | 01010831 | Nextgen In-Vitro Diagnostics Private Limited | Director |
| Varun Chopra | 01044311 | Nextgen In-Vitro Diagnostics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashok Kumar Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashok Kumar Jain
Ashok Kumar Jain currently holds 2 directorships: Alpha Alternatives Msar Llp (Partner, since 03 Jun 2024, revenue ₹4,486 Cr (FY 2025)); Nextgen In-Vitro Diagnostics Private Limited (Director, since 02 Mar 2020, revenue ₹1.87 Cr (FY 2024)).
Ashok Kumar Jain was first appointed on 01 Dec 2006 as Whole-Time Director at Avantor Performance Materials India Private Limited. The most recent appointment on record is 03 Jun 2024 at Alpha Alternatives Msar Llp.
The 2 current companies of Ashok Kumar Jain that report revenue have a combined latest revenue of ₹4,488 Cr: Alpha Alternatives Msar Llp ₹4,486 Cr (FY 2025); Nextgen In-Vitro Diagnostics Private Limited ₹1.87 Cr (FY 2024).
Ashok Kumar Jain held 2 earlier board appointments: Avantor Performance Materials India Private Limited (Whole-Time Director, 01 Dec 2006 to 27 Aug 2019); J.T. Baker Chemicals Private Limited (Director, from 10 May 2012).
The current boards of Ashok Kumar Jain's companies include Mudit Singhania (Alpha Alternatives Msar Llp), Shreyans Hitendrakumar Mehta (Alpha Alternatives Msar Llp), Devashish Ohri (Nextgen In-Vitro Diagnostics Private Limited), Sushil Mehta (Nextgen In-Vitro Diagnostics Private Limited), Varun Chopra (Nextgen In-Vitro Diagnostics Private Limited).